← The Wire·Earnings·

Morgan Stanley downgrades Lemonade to Equalweight, citing valuation concerns

Morgan Stanley has downgraded Lemonade (LMND) to Equalweight from Overweight, citing valuation concerns after the stock's significant rally. This move by a major bank creates a potential short-term pullback opportunity, especially given LMND's history of volatility.

The story

Morgan Stanley has revised its rating on Lemonade (LMND) stock, moving it from Overweight to Equalweight. The primary driver behind this downgrade is valuation, following a substantial run-up in LMND's share price over recent months.

Lemonade, an insurance technology company leveraging AI and behavioral economics, has seen its stock gain considerable traction. However, the analyst's view suggests that the current valuation no longer justifies an Overweight rating, implying that much of the near-term upside may already be priced in.

This downgrade comes as LMND reported revenues of $737.9 million, a robust 40.2% year-over-year increase for the fiscal year ending 2025-12-31. Despite strong top-line growth, the company still faces significant profitability challenges, with negative net margins of -22.5% and diluted EPS of -$2.24.

The market reaction to such downgrades can be swift, particularly for growth stocks with high valuations and negative profitability. Traders will be watching to see if this rating change triggers a wave of profit-taking or if the underlying growth narrative continues to support the stock.

Our read · Wed, Jul 8

Morgan Stanley's downgrade of Lemonade (LMND) to Equalweight on valuation raises the question of whether the stock's recent rally is sustainable or due for a correction.

Why. Morgan Stanley's downgrade to Equalweight, specifically citing valuation concerns, suggests that the stock's recent appreciation has outpaced fundamental improvements, especially given its -22.5% net margins and -$2.24 dil. EPS. This provides a tactical short opportunity for profit-taking.

Both cases

The case it holdsThe bull case for LMND rests on its impressive 40.2% YoY revenue growth, suggesting strong underlying business momentum and market adoption for its insurance technology.
The case it breaksThe bear case is strengthened by Morgan Stanley's downgrade on valuation, highlighting that despite revenue growth, the company's significant negative net margins (-22.5%) and diluted EPS (-$2.24) make its current price unsustainable.

What could change this view: A strong rebound in the broader tech sector or unexpected positive news on profitability could quickly reverse the trend.

Lemonade stock page →
Your side is graded privately against closes after 10 trading days. Research, not advice.

Who reported it · 1

Keep reading

Latest on the Wire

Trump threatens overseas AI data-centre ban for US firmsBitcoin drops below $59,000 as cash rush revives summer-low testGreer says US chip curbs will close China export-control loopholesBlackRock bitcoin ETF posts $541.1 million outflow as tech sell-off spreadsPoland says Russian missiles and drone crashed during Ukraine assaultContinue on the Wire →

Top this week

Nvidia allies lobby board to bring back Jensen Huang as CEONvidia chair rules out Huang return as CEO after 75% sales outlookAnthropic Said to Guide IPO Pricing Above Market RangeNvidia interim CEO Colette Kress faces first earnings test after HuangAnthropic IPO could become the largest in US history on Thursday
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.

About this report

Reported by Investing.com as Morgan Stanley downgrades Lemonade stock rating to Equalweight on valuation, . Who answers for this

The only report in this record. Closes are licensed end-of-day data from Databento; the move after a story is its first close against the close before it. How this is decided →

Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →